Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1627 results

Which valve for which patient? - Part 1: simple anatomy

17 May 2023 – From EuroPCR 2023

Explore this session to gain insights into the influence of valve design on hemodynamic performance and durability, understand its implications for risk factors associated with TAVI in bicuspid aortic valves, and grasp the relationship between valve design, implantation techniques, and the emergence of new conduction abnormalities...

Which valve for which patient? - Part 1: simple anatomy

Valve-in-valve - LIVE case

17 May 2023 – From EuroPCR 2023

Study the case of a 76-year-old female patient with BMI 32, atrial fibrillation, diabetes, mid chronic kidney disease and history of aortic stenosis, whose Perimount Magna Ease 21 (mismatch) surgical bioprosthesis, implanted in 2016, degenerated, with preserved left ventricular function. 

An Evolut Pro 26 was implanted in...

Valve-in-valve - LIVE case

Pitfalls during primary PCI in STEMI patients and TAVI procedure

17 May 2023 – From EuroPCR 2023

How should I treat? Explore this series of cases designed to enable you to gain knowledge of techniques for managing unexpected complications during primary PCI, tackle complex anatomical challenges with limited resources, encourage innovation and develop out-of-the-box solutions. In addition, discover effective lifesaving strategies to use...

Pitfalls during primary PCI in STEMI patients and TAVI procedure

Which valve for which patient? - Part 2: complex anatomy

17 May 2023 – From EuroPCR 2023

Consult this session if you want to understand how to optimize the hemodynamic performance after VinV procedures, to identify patients at risk for coronary occlusion and how to prevent this in VinV procedures, and to learn how to gain safe vascular access in challenging peripheral anatomies.

Which valve for which

How to optimise TAVI pathway

17 May 2023 – From EuroPCR 2023

Consult this series of slides to enhance understanding on the TAVI pathway, get a defined idea of the role of a TAVI coordinator in patient journeys, and explore organisational dynamics in diverse TAVI centres.

How to optimise TAVI pathway

TAVI for bicuspid anatomy: beyond type I LR

17 May 2023 – From EuroPCR 2023

Consult this session if you want to understand the challenges of bicuspid aortic stenosis patients, type 0 in particular, to review contemporary sizing methods in bicuspid aortic stenosis, and to tailor the implant technique to individual patient.

TAVI for bicuspid anatomy:

SOLACI research - Developing original research across Latin America

17 May 2023 – From EuroPCR 2023

In these slides, get an insight into real-world bifurcation lesion management in Latin America, diverse STEMI reperfusion access in this region, and limitations to widespread TAVI adoption, along with the Latin America TAVI guidelines.

SOLACI research - Developing original research across Latin America

Tailored device choice and implant technique to optimise TAVI procedural outcomes

17 May 2023 – From EuroPCR 2023

Discover the key factors to consider in selecting the optimal valve and implant technique for transcatheter aortic valve implantation (TAVI) to achieve optimal procedural outcomes. Gain insights into the impact of device choice and implantation technique on coronary access following TAVI and learn valuable strategies for...

Tailored device choice

Shock with valve disease - Part 1

17 May 2023 – From EuroPCR 2023

Discover here some compelling clinical cases on shock and valve disease. Experience real-life scenarios that will help you gain valuable knowledge and improve your clinical decision-making skills.

Shock and valve disease

Aortic complications

17 May 2023 – From EuroPCR 2023

Enhance your understanding of managing aortic complications effectively by exploring a comprehensive series of clinical cases presented at EuroPCR. Cases studied include in particular – How to manage iatrogenic aortic dissection during TAVI- Pseudoaneurysm after TAVI, how to close the hole- Aortic dissection following TAVI and...

Aortic complications

Pushing TAVI boundaries: daily practice challenges

17 May 2023 – From EuroPCR 2023

Pushing the limits of TAVI is a challenge you face in your daily practice? See how some of your colleagues have tackled the same challenge through this series of cases. To mention a few: TAVR in patient with a large membranous ventricular- Chronic kidney disease and...

Pushing TAVI boundaries

Next generation balloon expandable TAVR and thin strut BRS - Science and clinical update

17 May 2023 – From EuroPCR 2023

Join this session for an update on the science and clinical advancements in next-generation balloon-expandable transcatheter aortic valve replacement (TAVR) and thin strut bioresorbable scaffolds (BRS). Discover how these innovative technologies can improve clinical outcomes by exploring case-based challenging scenarios and learn effective strategies for tackling...

Next generation balloon

Selecting the right first valve to secure lifetime management

17 May 2023 – From EuroPCR 2023

The treatment of young and less at-risk patients clearly shows that their age, life expectancy and risk factors are essential parameters to be taken into account in the choice of TAVI and therefore it is essential to think about future coronary access after TAVI. Watch the...

Selecting the right first

Cutting-edge technologies: clinical updates on TES, BRS, TAVR and LAA closure

17 May 2023 – From EuroPCR 2023

Watch this session to find out more about the three-year outcomes of the FUTURE-II Trial, the TARGET clinical trial roadmap, the TARGET IV NA Trial update, the twelve-month outcomes of the SAVE PROTECT Trial, and the quantitative aortographic assessment of regurgitation in patients treated with VitaFlow.

Cutting-edge technologies:

Long-term valve performance for the next decade and beyond

17 May 2023 – From EuroPCR 2023

How can TAVI outcomes be made better for younger patients with longer life horizons? Check-out in this session where you also will be able to gain in the understanding of the structural challenges of providing TAVI services and see how innovation can contribute to optimal outcomes and...

Long-term valve performance

Increase the complexity: multivalvular coronary interventions

17 May 2023 – From EuroPCR 2023

Investigate the increasing complexity of multivalvular coronary interventions in this insightful case-based presentation. Witness the complex challenges faced and discover the innovative approaches used to navigate the complex procedures.

Multivalvular coronary interventions

Imaging and procedural techniques to optimise outcomes in Bicuspid Aortic Valve patients

17 May 2023

An 80-year-old male presented with severe symptomatic bicuspid aortic valve stenosis and a challenging anatomy for TAVI. Which TAVI device, access site and techniques would you use for treating this patient?

Author

Radoslaw Parma
Imaging and procedural techniques to optimise outcomes in Bicuspid Aortic Valve patients

Latest CoreValve Evolut platform’s clinical evidence: impact on current TAVI practice

17 May 2023 – From EuroPCR 2023

Watch this video in which Didier Tchétché, Nicolas Van Mieghem and Matthias Götberg were invited to talk about durability data, with special emphasis on the 5-year bioprosthetic valve dysfunction (BVD) data presented during EuroPCR 2023.

They begin by recalling what bioprosthetic valve dysfunction is, and how it...

Latest CoreValve Evolut

EuroPCR 2023 Hotlines / Late-Breaking Trials: TAVI

16 May 2023 – From EuroPCR 2023

Discover the conclusions of various studies and registries about TAVI: 5-year outcomes with the ACURATE neo2 valve: the Neo AS CE-mark study; TAVR in patients with cardiogenic shock which evaluated outcomes of consecutive TAVRs in patients with CS using contemporary SAPIEN 3 and SAPIEN 3 ultra...

TAVI Hotlines EuroPCR2023

TAVI in patients with long-life expectancy - LIVE case

16 May 2023 – From EuroPCR 2023

Watch the case of a 75-year-old male patient with history of TIA, symptomatic severe aortic stenosis with RBBB, and preserved LV function. The heart team's decision was to perform TAVI with PCI on LAD a few days before procedure.

First, a cerebral protection device (Sentinel) was implanted....

TAVI in patients with long-life expectancy